Literature DB >> 6885049

Expression of the fragile (X) chromosome in an interspecific somatic cell hybrid.

R L Nussbaum, S D Airhart, D H Ledbetter.   

Abstract

Interspecific somatic cell hybrids were constructed between a Chinese hamster lung cell line deficient in hypoxanthine phosphoribosyltransferase and two lymphoblastoid cultures (GM 4025 and GM 3200) from unrelated males affected with the fragile (X) syndrome. Thirteen independent colonies survived selection in hypoxanthine-azaserine, while only one colony survived selection in hypoxanthine-aminopterin-thymidine. One hybrid formed from GM 4025 was found to contain a human X chromosome as the only detectable human chromosome in the majority of cells analyzed. Induction of fragile (X) expression in this hybrid at frequencies up to 20% was achieved by treatments with 5-fluoro-2'-deoxyuridine (5 X 10(-8) M or 1 X 10(-7) M) or methotrexate (5 X 10(-6) or 1 X 10(-5) for 12 h. Use of the somatic cell hybrid system may allow study of the fragile (X) from different patients on a homogeneous xenogeneic background and may provide a better system for characterization of the fragile (X) at the biochemical and molecular level.

Entities:  

Mesh:

Year:  1983        PMID: 6885049     DOI: 10.1007/bf00327113

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium.

Authors:  G R Sutherland
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

2.  Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture.

Authors:  G R Sutherland
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

3.  The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.

Authors:  R Brookwell; A Daniel; G Turner; J Fishburn
Journal:  Am J Med Genet       Date:  1982-10

4.  Expression of the marker (X) (q28) in lymphoblastoid cell lines.

Authors:  P A Jacobs; P A Hunt; M Mayer; J C Wang; G R Boss; R W Erbe
Journal:  Am J Hum Genet       Date:  1982-07       Impact factor: 11.025

Review 5.  Marker (X)-linked mental retardation.

Authors:  G Turner; P Jacobs
Journal:  Adv Hum Genet       Date:  1983

6.  Expression in lymphocyte and fibroblast culture of the fragile X chromosome: a new technical approach.

Authors:  M G Mattei; J F Mattei; I Vidal; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.

Authors:  G Turner; A Daniel; M Frost
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

8.  5-Fluoro-2'-deoxyuridine induction of the fragile site on Xq28 associated with X linked mental retardation.

Authors:  N Tommerup; H Poulsen; K Brøndum-Nielsen
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

9.  Simultaneous identification of chromatid replication and of human chromosomes in metaphases of man-mouse somatic cell hybrids. (With 1 color plate).

Authors:  B Alhadeff; M Velivasakis; M Siniscalco
Journal:  Cytogenet Cell Genet       Date:  1977

10.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

View more
  16 in total

1.  Alu-primed polymerase chain reaction for regional assignment of 110 yeast artificial chromosome clones from the human X chromosome: identification of clones associated with a disease locus.

Authors:  D L Nelson; A Ballabio; M F Victoria; M Pieretti; R D Bies; R A Gibbs; J A Maley; A C Chinault; T D Webster; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

2.  Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis.

Authors:  K A Ellison; C P Fill; J Terwilliger; L J DeGennaro; A Martin-Gallardo; M Anvret; A K Percy; J Ott; H Zoghbi
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

3.  Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X.

Authors:  V J Hyland; K E Fernandez; D F Callen; R N MacKinnon; E Baker; K Friend; G R Sutherland
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

4.  The anonymous polymorphic DNA clone D1S1, previously mapped to human chromosome 1p36 by in situ hybridization, is from chromosome 3 and is duplicated on chromosome 1.

Authors:  M E Goode; P vanTuinen; D H Ledbetter; S P Daiger
Journal:  Am J Hum Genet       Date:  1986-04       Impact factor: 11.025

5.  Five polymorphic microsatellite VNTRs on the human X chromosome.

Authors:  J A Luty; Z Guo; H F Willard; D H Ledbetter; S Ledbetter; M Litt
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

6.  Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources.

Authors:  D L Nelson; S A Ledbetter; L Corbo; M F Victoria; R Ramírez-Solis; T D Webster; D H Ledbetter; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Ultrastructural and biochemical comparisons of nuclear matrices prepared by high salt or LIS extraction.

Authors:  H C Smith; R L Ochs; D Lin; A C Chinault
Journal:  Mol Cell Biochem       Date:  1987-09       Impact factor: 3.396

Review 8.  Recently recognized chromosomal defects of clinical importance.

Authors:  M Pembrey; M Baraitser
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

9.  Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.

Authors:  J M Puck; R L Nussbaum; M E Conley
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

10.  Isolation of anonymous DNA sequences from within a submicroscopic X chromosomal deletion in a patient with choroideremia, deafness, and mental retardation.

Authors:  R L Nussbaum; J G Lesko; R A Lewis; S A Ledbetter; D H Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.